We are attaching herewith proceedings of 43rd Annual General Meeting of the Company.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivanza Biosciences held its 43rd AGM on September 25, 2025 at 3:15 PM via video conferencing, lasting only about 7 minutes (concluded at 3:22 PM). Chairman and Managing Director Mr. Mehta J.A. presided, with the CFO briefly apprising members of financial performance and future prospects, though no shareholder raised any questions or queries. Six items of business were put to vote, including adoption of audited standalone and consolidated financial statements for FY ended March 31, 2025, re-appointment of Mr. Parikh H.A. as a director retiring by rotation, regularization of two additional directors (Mr. Hitesh Rijwani as Independent and Mr. Sarang Pathak as Non-Executive Non-Independent), appointment of a secretarial auditor for five years from FY 2025-26, and alteration of the object clause of the Memorandum of Association. Remote e-voting was conducted through CDSL from September 22 to 24, 2025, and the combined voting results are to be announced within 48 hours of the meeting's conclusion.
The short duration and absence of shareholder questions suggest a routine meeting, but investors should watch for the e-voting results on six resolutions, particularly the alteration of the MOA's object clause which could signal a change in business direction. Director regularization and secretarial auditor appointment are standard housekeeping items with limited price impact.